• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病疾病轨迹动态建模的个性化框架

A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia.

作者信息

Savvopoulos Symeon, Misener Ruth, Panoskaltsis Nicki, Pistikopoulos Efstratios N, Mantalaris Athanasios

出版信息

IEEE Trans Biomed Eng. 2016 Nov;63(11):2396-2404. doi: 10.1109/TBME.2016.2533658. Epub 2016 Feb 23.

DOI:10.1109/TBME.2016.2533658
PMID:26929022
Abstract

Chronic lymphocytic leukemia (CLL) is the most common peripheral blood and bone marrow cancer in the developed world. This manuscript proposes mathematical model equations representing the disease dynamics of B-cell CLL. We interconnect delay differential cell cycle models in each of the tumor-involved disease centers using physiologically relevant cell migration. We further introduce five hypothetical case studies representing CLL heterogeneity commonly seen in clinical practice and demonstrate how the proposed CLL model framework may capture disease pathophysiology across patient types. We conclude by exploring the capacity of the proposed temporally- and spatially distributed model to capture the heterogeneity of CLL disease progression. By using global sensitivity analysis, the critical parameters influencing disease trajectory over space and time are: 1) the initial number of CLL cells in peripheral blood, the number of involved lymph nodes, the presence and degree of splenomegaly; 2) the migratory fraction of nonproliferating as well as proliferating CLL cells from bone marrow into blood and of proliferating CLL cells from blood into lymph nodes; and 3) the parameters inducing nonproliferative cells to proliferate. The proposed model offers a practical platform that may be explored in future personalized patient protocols once validated.

摘要

慢性淋巴细胞白血病(CLL)是发达国家最常见的外周血和骨髓癌症。本手稿提出了代表B细胞CLL疾病动态的数学模型方程。我们利用生理相关的细胞迁移,将每个肿瘤累及疾病中心的延迟微分细胞周期模型相互连接起来。我们进一步引入了五个代表临床实践中常见的CLL异质性的假设案例研究,并展示了所提出的CLL模型框架如何能够涵盖不同患者类型的疾病病理生理学。我们通过探索所提出的时空分布模型捕捉CLL疾病进展异质性的能力来得出结论。通过全局敏感性分析,影响疾病在空间和时间上轨迹的关键参数为:1)外周血中CLL细胞的初始数量、受累淋巴结的数量、脾肿大的存在情况和程度;2)非增殖性以及增殖性CLL细胞从骨髓迁移到血液中的比例,以及增殖性CLL细胞从血液迁移到淋巴结中的比例;3)诱导非增殖细胞增殖的参数。一旦经过验证,所提出的模型提供了一个实用平台,可在未来的个性化患者治疗方案中进行探索。

相似文献

1
A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病疾病轨迹动态建模的个性化框架
IEEE Trans Biomed Eng. 2016 Nov;63(11):2396-2404. doi: 10.1109/TBME.2016.2533658. Epub 2016 Feb 23.
2
Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.采用荧光原位杂交技术对B细胞慢性淋巴细胞白血病患者外周血、骨髓和淋巴结中的12号三体进行评估。
Haematologica. 1999 Mar;84(3):212-7.
3
Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?小淋巴细胞淋巴瘤和慢性淋巴细胞白血病:它们是同一种疾病吗?
Cancer J. 2012 Sep-Oct;18(5):396-403. doi: 10.1097/PPO.0b013e31826cda2d.
4
[Molecular pathogenesis of chronic lymphocytic leukemia with emphasis on cell cycle regulation and apoptosis].[慢性淋巴细胞白血病的分子发病机制,重点关注细胞周期调控与凋亡]
Cas Lek Cesk. 2004;143(2):84-9.
5
[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].[慢性淋巴细胞增殖性疾病白血病类型的临床和实验室预后参数]
Acta Med Croatica. 2008 Oct;62(4):351-64.
6
Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives.慢性淋巴细胞白血病:来自淋巴结和骨髓的见解及临床观点
Coll Antropol. 2010 Mar;34(1):309-13.
7
Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.循环B细胞慢性淋巴细胞白血病细胞向淋巴结和骨髓的迁移能力受损。
Cancer Res. 2009 Apr 1;69(7):3121-30. doi: 10.1158/0008-5472.CAN-08-4136. Epub 2009 Mar 17.
8
Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.在Eμ-TCL1小鼠模型中,小窝蛋白-1的缺失导致慢性淋巴细胞白血病的发展延迟。
Exp Hematol. 2016 Jan;44(1):30-7.e1. doi: 10.1016/j.exphem.2015.09.005. Epub 2015 Oct 3.
9
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤累及骨髓的增殖中心:一项临床病理分析
Ann Diagn Pathol. 2016 Dec;25:15-19. doi: 10.1016/j.anndiagpath.2016.07.011. Epub 2016 Aug 18.
10
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.趋化因子受体CXCR4和CCR7的表达与B细胞慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的疾病进展
Mayo Clin Proc. 2004 Mar;79(3):318-25. doi: 10.4065/79.3.318.

引用本文的文献

1
Quantitative pharmacology of dual-targeted bicistronic CAR-T-cell therapy using multiscale mechanistic modeling.使用多尺度机制模型的双靶点双顺反子CAR-T细胞疗法的定量药理学
CPT Pharmacometrics Syst Pharmacol. 2025 Feb;14(2):229-245. doi: 10.1002/psp4.13259. Epub 2024 Nov 7.
2
Development of a multiscale mechanistic modeling framework integrating differential cellular kinetics of CAR T-cell subsets and immunophenotypes in cancer patients.开发一个多尺度机械建模框架,整合癌症患者中 CAR T 细胞亚群和免疫表型的差异细胞动力学。
CPT Pharmacometrics Syst Pharmacol. 2023 Sep;12(9):1285-1304. doi: 10.1002/psp4.13009. Epub 2023 Aug 18.
3
Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.
Hes1 通过调节 PTEN 表达来控制慢性淋巴细胞白血病细胞的增殖和凋亡。
Mol Biotechnol. 2022 Dec;64(12):1419-1430. doi: 10.1007/s12033-022-00476-2. Epub 2022 Jun 15.
4
Improving personalized tumor growth predictions using a Bayesian combination of mechanistic modeling and machine learning.利用机制建模和机器学习的贝叶斯组合改进个性化肿瘤生长预测
Commun Med (Lond). 2021 Jul 29;1:19. doi: 10.1038/s43856-021-00020-4. eCollection 2021.
5
Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.成人新诊断慢性淋巴细胞白血病的预后模型:一项系统评价和荟萃分析。
Cochrane Database Syst Rev. 2020 Jul 31;7(7):CD012022. doi: 10.1002/14651858.CD012022.pub2.
6
Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.白血病中使用分子数据分析的智能技术:个性化医疗支持系统的机遇
Biomed Res Int. 2017;2017:3587309. doi: 10.1155/2017/3587309. Epub 2017 Jul 25.